Navigation Links
Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy-Defibrillators - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
Date:11/7/2011

Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, the UK, Revenue ($m), 2003-2010 28

Figure 9: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, the UK, Revenue ($m), 2010-2017 29

Figure 10: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Germany, Revenue ($m), 2003-2010 30

Figure 11: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Germany, Revenue ($m), 2010-2017 31

Figure 12: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, France, Revenue ($m), 2003-2010 32

Figure 13: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, France, Revenue ($m), 2010-2017 33

Figure 14: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Italy, Revenue ($m), 2003-2010 34

Figure 15: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Italy, Revenue ($m), 2010-2017 35

Figure 16: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Spain, Revenue ($m), 2003-2010 36

Figure 17: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Spain, Revenue ($m), 2010-2017 37

Figure 18: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Japan, Revenue ($m), 2003-2010 38

Figure 19: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Japan, Revenue ($m), 2010-2017 39

Figure 20: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Chi
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine technology :

1. New Implantable Lenses Can Reduce the Need for Glasses After Cataract Surgery
2. Can Implantable Devices for Heart Failure Help Assess Risk of Future Adverse Events for Heart Failure Patients?
3. Implantable Defibrillators Lower Risk of Death in Older Heart Patients
4. Boston Scientific Data Show Real-World Survival Rates for Implantable Cardiac Device Patients Exceed Rates From Clinical Trials
5. New MADIT II Clinical Data Analysis Shows Long-Term Survival Benefit for Implantable Defibrillator Therapy
6. VisionCare Implantable Telescope Technology Presentations Featured at Upcoming American Academy of Ophthalmology and Ophthalmology Innovation Summit Meetings
7. AHRQ and American College of Cardiology Collaborate On Study of Implantable Cardioverter Defibrillators
8. FDA Advisory Panel Votes 15 to 0 in Favor of Approving Envoy Medicals Esteem(R) Fully Implantable Hearing Restoration System
9. Access MediQuip Announces Release of the Countrys First Centralized Recall Management Service(SM) for Implantable Devices
10. FDA Approves First of Its Kind, Fully Implantable (Surgically), Invisible, Prosthetic Hearing Restoration Device
11. Angel Medical Systems Receives CE Mark Approval for the AngelMed Guardian, an Implantable Device Designed to Provide Early Warning of a Heart Attack
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... , Sept. 15, 2014 /CNW/ - Health Minister Rona ... will make available for donation over $2.5 million in personal ... aid in the global response to the Ebola outbreak in ... WHO reported a shortage of equipment in the affected countries ... by front-line workers in the affected countries. ...
(Date:9/15/2014)... 15, 2014 /PRNewswire/ -  Pivotal Therapeutics Inc. (OTCQX:PVTTF; ... company with a focus on Omega-3 therapies for ... the Board of Directors approved the granting of ... the close of business on Friday, September 12, ... common shares of the Company were granted in ...
(Date:9/15/2014)... /PRNewswire-iReach/ -- Asthma is a chronic inflammatory lung ... most commonly starts in childhood. It is a ... airways, leading to airflow limitation and airway hyper-responsiveness ... endogenous and exogenous irritants. Exposure to irritants instigates ... the airways, tightening of the respiratory muscles, and ...
Breaking Medicine Technology:Canada offers essential protective equipment to help stop the spread of Ebola in West Africa 2Canada offers essential protective equipment to help stop the spread of Ebola in West Africa 3Pivotal Therapeutics Grants Incentive Stock Options 2Asthma Market to Reach 161.02 million Cases in 10MM by 2023 2Asthma Market to Reach 161.02 million Cases in 10MM by 2023 3Asthma Market to Reach 161.02 million Cases in 10MM by 2023 4Asthma Market to Reach 161.02 million Cases in 10MM by 2023 5
... DIEGO, Feb. 29, 2012  Polaris Group (Polaris) today announced ... Phase 1 clinical trial evaluating its lead cancer therapeutic, ... emphasis on leukemia, lymphoma and sarcoma cancers. These three ... in the pediatric population. Patients with advanced ...
... Md., Feb. 29, 2012  Northwest Biotherapeutics (OTC.BB: NWBO) (NW ... Ph.D., MA, MBA, will be presenting at the Cancer ... pm ET on Wednesday, February 29, 2012, in Boston, Massachusetts ... (Logo: http://photos.prnewswire.com/prnh/20110329/SF73084LOGO ) ...
Cached Medicine Technology:Polaris Group Doses First Patient in Phase 1 Clinical Trial of Lead Therapeutic Candidate ADI-PEG 20 in Pediatric Patients with Emphasis on Leukemia, Lymphoma and Sarcoma 2Polaris Group Doses First Patient in Phase 1 Clinical Trial of Lead Therapeutic Candidate ADI-PEG 20 in Pediatric Patients with Emphasis on Leukemia, Lymphoma and Sarcoma 3NW Bio to Present at the Cancer Immunotherapy Summit 2NW Bio to Present at the Cancer Immunotherapy Summit 3NW Bio to Present at the Cancer Immunotherapy Summit 4
(Date:9/16/2014)... 16, 2014 Wholelifeinsurancecompanies.org has released a ... life insurance with a bad heart condition. , Clients ... affordable life insurance if they compare quotes. Most agencies ... decision depend on the actual and past medical condition. ... caused several heart attacks in the past, his or ...
(Date:9/16/2014)... comparison of five-year sexual function outcomes, as ... radiotherapy (EBRT) versus combination EBRT plus brachytherapy, ... therapy makes cure possible without compromising long-term ... at the American Society for Radiation Oncology,s ... study examined the patient-reported outcomes of 91 ...
(Date:9/16/2014)... than any other workplace incident, a statistic that transport ... conference being hosted by QUT,s Centre for Accident Research ... Safety in Transport Conference (OSIT) to be held on ... together experts from all facets of transport safety including ... and safety. , CARRS-Q research fellow Darren Wishart said ...
(Date:9/16/2014)... have developed a new cocktail that is highly ... pluripotent stem cells. , Regenerative medicine is a ... lost or damaged cells, tissues or organs through ... embryos can trigger ethical concerns, a good solution ... state using a combination of reprogramming factors. ...
(Date:9/16/2014)... 2014 An experimental positron emission tomography ... while a person is still alive, according to a ... at Mount Sinai, and at Molecular Neuroimaging (MNI) LLC ... journal Translational Psychiatry. , Specifically, the study results suggest ... is designed to latch onto a protein called tau ...
Breaking Medicine News(10 mins):Health News:No Exam Life Insurance for Clients Who Have a Bad Heart Condition! 2Health News:Prostate cancer patients surveyed 5 years after vessel-sparing RT report preserved sexual function 2Health News:Prostate cancer patients surveyed 5 years after vessel-sparing RT report preserved sexual function 3Health News:CARRS-Q Host International Transport Safety Conference 2Health News:Scientists create therapy-grade stem cells using new cocktail to reprogram adult cells 2Health News:Neuroimaging Technique Identifies Concussion-Related Brain Disease in Living Brain 2Health News:Neuroimaging Technique Identifies Concussion-Related Brain Disease in Living Brain 3Health News:Neuroimaging Technique Identifies Concussion-Related Brain Disease in Living Brain 4
... His Royal Highness, The Duke of York,was the ... to mark the United States,launch of UK-based specialty ... US product, Sancuso, is currently under,consideration for licensing ... (Photo: http://www.newscom.com/cgi-bin/prnh/20080214/NYTH111 ), Prince Andrew ...
... validity of self-reported tobacco use in research, care , , ... more likely than younger ones to deny they smoke ... That,s the conclusion of a study that analyzed data ... took part in the third National Health and Nutrition ...
... Dividend, ACTON, Mass., Feb. 14 Psychemedics,Corporation (Amex: ... results for the period ended December 31, 2007, which ... The Company,also announced a quarterly dividend of $0.15 per ... 2008 to be paid on March 21, 2008.,This will ...
... Weight Watchers,International, Inc. (NYSE: WTW ) today announced results ... 2007., Fourth Quarter 2007 Results, For the fourth ... $344.0 million. Fully diluted earnings per share in the fourth,quarter ... period. The prior,year included a benefit of $0.06 per share ...
... N.J., Feb. 14 TeamStaff, Inc.,(Nasdaq: TSTF ), ... announced its financial results for the first,quarter ended December ... months ended December 31, 2007 was,$0.1 million as compared ... last year. Income from continuing operations was $0.04 million ...
... 14 /PRNewswire-USNewswire/ - The Foundation,for Taxpayer and Consumer ... HMO,regulator calling for swift action to end Blue ... medical records for any,excuse to dump patients who ... the Los Angeles Times on Wednesday,that the practice ...
Cached Medicine News:Health News:His Royal Highness The Duke of York Helps Launch UK-Based Pharmaceutical Company, ProStrakan, in the United States 2Health News:His Royal Highness The Duke of York Helps Launch UK-Based Pharmaceutical Company, ProStrakan, in the United States 3Health News:Older Smokers More Likely to Deny Habit 2Health News:Psychemedics Corporation Announces Year End Results Record Annual and Quarterly Revenue 2Health News:Psychemedics Corporation Announces Year End Results Record Annual and Quarterly Revenue 3Health News:Psychemedics Corporation Announces Year End Results Record Annual and Quarterly Revenue 4Health News:Psychemedics Corporation Announces Year End Results Record Annual and Quarterly Revenue 5Health News:Psychemedics Corporation Announces Year End Results Record Annual and Quarterly Revenue 6Health News:Weight Watchers Announces Fourth Quarter and Full Year 2007 Results 2Health News:Weight Watchers Announces Fourth Quarter and Full Year 2007 Results 3Health News:Weight Watchers Announces Fourth Quarter and Full Year 2007 Results 4Health News:Weight Watchers Announces Fourth Quarter and Full Year 2007 Results 5Health News:Weight Watchers Announces Fourth Quarter and Full Year 2007 Results 6Health News:Weight Watchers Announces Fourth Quarter and Full Year 2007 Results 7Health News:TeamStaff Reports First Quarter Net Income and $0.7 Million Income Improvement From Continuing Operations Over Prior Year 2Health News:TeamStaff Reports First Quarter Net Income and $0.7 Million Income Improvement From Continuing Operations Over Prior Year 3Health News:TeamStaff Reports First Quarter Net Income and $0.7 Million Income Improvement From Continuing Operations Over Prior Year 4Health News:TeamStaff Reports First Quarter Net Income and $0.7 Million Income Improvement From Continuing Operations Over Prior Year 5Health News:TeamStaff Reports First Quarter Net Income and $0.7 Million Income Improvement From Continuing Operations Over Prior Year 6Health News:TeamStaff Reports First Quarter Net Income and $0.7 Million Income Improvement From Continuing Operations Over Prior Year 7Health News:TeamStaff Reports First Quarter Net Income and $0.7 Million Income Improvement From Continuing Operations Over Prior Year 8Health News:TeamStaff Reports First Quarter Net Income and $0.7 Million Income Improvement From Continuing Operations Over Prior Year 9Health News:FTCR: Gov. Schwarzenegger Must Follow Through on Call to Ban Blue Cross From Using Doctors as Double-Agents to Dump Sick Patients 2
... three-dimensional VCS technology, providing ... efficiency in white cell ... With its reputation for ... is an affordable solution ...
Creatinine Test Kit (enzymatic), Wavelength: 340 nm. Linear range: up to 20 mg/dL....
For the quantitative determination of Creatine Kinase in serum....
For the qualitative determination of magnesium in serum....
Medicine Products: